Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2025 ∙ Kalantari, Y. Mirahmadi, S. M. S. Alilou, S. Sadeghi, S. Aryanian, Z. Jafarzadeh, A. Goodarzi, A.

A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Thiyagarajan, G. Nagasubramanian, V. R. Ravichandran, S. L. Baskaran, P. Thangam, D. C. Sankaranarayanan, R. K. Undela, K. Sridevi, B. Pelluri, R. Gurram, P. C. Rajangam, J.

Acceptance and reluctance of COVID-19 vaccination among the general population: a systematic review and meta-analysis of cross-sectional studies

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Min Htike, W. Y. Zhang, M. Wu, Z. Zhou, X. Lyu, S. Kam, Y. W.

Addressing Vaccine Hesitancy in College Students Post COVID-19 Pandemic: A Systematic Review Using COVID-19 as a Case Study

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mink, S. Wilhelm, F. Cadamuro, J. Reimann, P. Fraunberger, P.

Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Coyne, B. M. Ito, D. Tariq, A. Lew, S. Q. Kopp, J. Vinales, P. C. Malik, F. Gipson, P. E. Nobakht, E.

Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Tzang, C. C. Sheng, H. Kuo, V. F. Luo, C. A. Lin, T. A. Lee, Y. T. Huang, E. S. Wu, P. H. Tzang, B. S. Hsu, T. C.

Association between COVID-19 and New-Onset Autoimmune Diseases: Updated Systematic Review and Meta-Analysis of 97 Million Individuals

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Sadowski, J. Huk, J. Otulak, S. Zawilo, J. Klaudel, T. Roszak, M. Tenczynski, D. Buldak, R. J.

Association between Guillain-Barre syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Maggi, S. Fulop, T. De Vita, E. Limongi, F. Pizzol, D. Di Gennaro, F. Veronese, N.

Association between vaccinations and risk of dementia: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Herpes zoster
  • Tetanus
  • Diphtheria
  • Pertussis
  • Influenza
  • Pneumococcal disease
  • Poliomyelitis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sanftenberg, L. Kraeker, L. Walter, F. Tsiligianni, I. Bouloukaki, I. Roos, M. Gensichen, J.

Associations between common mental disorders and vaccination readiness against seasonal influenza and Covid-19 of chronically ill adult patients in primary care - a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Vink, K. Kusters, J. Wallinga, J.

Chrono-optimizing vaccine administration: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Hepatitis B
  • Hepatitis A
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...